Description
Okamet GMP 2 Tablet is a triple-drug oral antidiabetic formulation manufactured by Cipla Ltd. It contains Glimepiride 2mg, Metformin Hydrochloride 500mg (Sustained Release), and Pioglitazone 15mg. This medicine is prescribed to patients with Type 2 Diabetes Mellitus whose blood glucose is not adequately controlled with dual therapy or lifestyle modifications alone.
It provides comprehensive glycemic control by targeting different pathways responsible for high blood sugar, making it highly effective for long-term diabetes management.
How Okamet GMP 2 Works
-
Glimepiride (2mg): A sulfonylurea that stimulates the pancreas to release more insulin, thereby reducing high blood sugar after meals.
-
Metformin SR (500mg): A biguanide that lowers glucose production in the liver, delays intestinal absorption of sugar, and improves insulin sensitivity.
-
Pioglitazone (15mg): A thiazolidinedione that enhances the body’s response to insulin and improves glucose uptake in muscles and fat tissues.
This three-way mechanism ensures effective control of both fasting and postprandial (after-meal) blood glucose levels.
Uses of Okamet GMP 2 Tablet
-
Management of Type 2 Diabetes Mellitus in adults.
-
Helps control fasting and post-meal blood sugar levels.
-
Prevents the risk of diabetes-related complications such as:
-
Neuropathy (nerve damage)
-
Nephropathy (kidney damage)
-
Retinopathy (eye damage)
-
Cardiovascular complications (heart disease, stroke).
-
-
Useful for patients needing triple-drug therapy when single or dual drug therapy is not enough.
Dosage & Administration
-
Usually taken once daily with a meal (preferably breakfast or as directed by doctor).
-
Swallow whole with water; do not crush or chew.
-
Dose is individualized based on blood glucose levels and patient’s response.
-
Regular monitoring of blood sugar, HbA1c, kidney, and liver function is essential.
Precautions
-
Not for Type 1 Diabetes or diabetic ketoacidosis.
-
Caution in patients with heart failure, kidney or liver impairment.
-
Avoid alcohol (increases risk of lactic acidosis and hypoglycemia).
-
May cause weight gain and fluid retention (due to Pioglitazone).
-
Not recommended during pregnancy or breastfeeding unless advised by a doctor.
Possible Side Effects
-
Hypoglycemia (sweating, tremors, dizziness, weakness, hunger)
-
Gastrointestinal upset: nausea, vomiting, diarrhea (from Metformin)
-
Weight gain, fluid retention, ankle swelling (from Pioglitazone)
-
Headache or dizziness
-
Rare but serious: Lactic acidosis, liver dysfunction, or worsening of heart failure
Overall Benefit
Okamet GMP 2 Tablet provides a powerful triple-action therapy for effective control of Type 2 Diabetes. By combining Glimepiride, Metformin SR, and Pioglitazone, it helps achieve stable blood sugar control, reduces long-term diabetes complications, and improves the overall quality of life for patients needing intensive management.
Leave a Reply